Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Childhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Studyopen accessChildhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Study

Other Titles
Childhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Study
Authors
이소람윤종혁임재영최희원이재민서진경김지윤양유진박경미임영탁박지경최은미심예지김흥식박상규공섬김최은진박은실
Issue Date
2018
Publisher
대한소아혈액종양학회
Keywords
Venous thromboembolism; Pediatric patients; Epidemiology
Citation
Clinical Pediatric Hematology-Oncology, v.25, no.1, pp 43 - 49
Pages
7
Indexed
KCI
Journal Title
Clinical Pediatric Hematology-Oncology
Volume
25
Number
1
Start Page
43
End Page
49
URI
https://scholarworks.gnu.ac.kr/handle/sw.gnu/12812
DOI
10.15264/cpho.2018.25.1.43
ISSN
2233-5250
2233-4580
Abstract
Background: Venous thromboembolism (VTE) is rare in pediatric patients compared to adults, but it’s incidence is gradually increasing. The purpose of this study was to analyze the incidence, risk factors, and prognosis of pediatric patients with VTE in Korea. Methods: Between January 2000 and July 2017, 249,312 medical records of the patients older than 1 year who were hospitalized in the department of pediatrics of 10 university hospitals in Yeungnam region were retrospectively reviewed. Results: The overall incidence of VTE was 4.9 per 10,000 admissions. Of the total 123 patients, 80 (65.0%) were male and the median age was 10.8 years (range, 1.0-23.5 years). Magnetic resonance imaging was performed most frequently to confirm the diagnosis of VTE (43.1%). Thrombosis occurred in the cerebral vessels (46.3%), lower extremities (23.8%), pulmonary (19.5%), abdomen (9.8%), and upper extremities (4.1%). One hundred and six patients had underlying causes such as cancer (27.6%), infection (26.8%), intravenous catheter insertion (17.9%), and surgery (14.6%). Protein C was evaluated in 39 patients (31.7%), protein S in 40 (32.5%), antithrombin (AT) III in 52 (42.3%), and homocysteine in 21 (17.1%). Among them, one patient with a family history of AT III deficiency had SERPINC gene mutation. Seventy-seven patients (62.6%) started anticoagulation treatment. Most (52.0%) were treated for more than 90 days. Conclusion: Healthcare providers must be aware of the potential for VTE development in childhood. In the near future, a nationwide survey should be investigated to determine the incidence rate and the trends in VTE among Korean children.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Eun Sil photo

Park, Eun Sil
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE